High-activity natural killer
High-activity natural killer is a biological therapy with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer
Clinical Trials (6)
High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer
High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma
All 6 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 6